The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

multiBic potassium-free solution for haemodialysis/haemofiltration

Fresenius Medical Care Deutschland GmbHPA1350/009/001

Main Information

Trade NamemultiBic potassium-free solution for haemodialysis/haemofiltration
Active SubstancesSodium chloride
Calcium chloride dihydrate
Magnesium chloride hexahydrate
Glucose monohydrate
Sodium hydrogen carbonate
Dosage FormSolution for haemodialysis/haemofiltration
Licence HolderFresenius Medical Care Deutschland GmbH
Licence NumberPA1350/009/001

Group Information

ATC CodeB05ZB Hemofiltrates


License statusAuthorised
Licence Issued10/02/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back